©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3774-3785
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3774
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3774
Table 1 The association between phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 and clinical features in 90 hepatocellular carcinoma patients
| Characteristics | P-Rex1 expression1 | P value | χ2 | |
| High | Low | |||
| Age (yr) | ||||
| ≤ 50 | 13 | 11 | 0.634 | 0.227 |
| > 50 | 32 | 34 | ||
| Gender | ||||
| Male | 33 | 36 | 0.455 | 0.559 |
| Female | 12 | 9 | ||
| HBV infection | ||||
| Yes | 33 | 5 | < 0.001 | 35.709 |
| No | 12 | 40 | ||
| Lymph node invasion | ||||
| Yes | 37 | 11 | < 0.001 | 30.179 |
| No | 8 | 34 | ||
| Distant metastasis | ||||
| Yes | 22 | 2 | < 0.001 | 22.727 |
| No | 23 | 43 | ||
| AFP level (ng/mL) | ||||
| < 20 | 8 | 8 | < 0.001 | 14.708 |
| 20 ≤ AFP ≤ 200 | 6 | 22 | ||
| > 200 | 31 | 15 | ||
| Total | 45 | 45 | ||
- Citation: Cai Y, Zheng Q, Yao DJ. Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma. World J Clin Cases 2020; 8(17): 3774-3785
- URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3774.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3774